Divis Laboratories Share Price
- All
- News
-
Divi's Labs Shares Decline Over 6% After Q4 Earnings
Shares of Divi's Laboratories fell more than 6 per cent on Tuesday as the company's March quarter earnings failed to cheer investors. The stock dropped as much as 6.35 per cent to hit an intraday low of Rs 3,650.
-
Pharma Firm, India's Best-Performing Stock, Sees Wave of Optimistic Calls
In just about two weeks, at least four brokerages have raised their price targets on the shares of Divi's Laboratories -- one of the top producers of active pharmaceutical ingredients
-
Divis Lab Slumps 20% After US Regulator Issues Import Alert For Vizag Plant
Surjit Pal, pharma analyst at Prabhudas Lilladher, says Divis Lab shares could remain under pressure as its FY18 earnings would be hit due to the import alert.
-
Divi's Laboratories Slumps Over 30% In Just Two Days Over FDA Concerns
The Vizag plant is one of the biggest plants for Divi's. The company manufactures active pharmaceutical ingredients (APIs) and intermediates for generics among others at the Vizag manufacturing plant.
-
Divis Laboratories Announces Rs 80 Crore Bonanza For Employees
Divis Laboratories said that the special payment of Rs 79 crore will be reflected in its September quarter numbers.
-
Divis Laboratories Surges 8%, Hits New 52-Week High
Divis Laboratories shares surged over 8 per cent on Monday to hit a new 52-week high of Rs 2,129.
-
Divi's Labs Shares Decline Over 6% After Q4 Earnings
Shares of Divi's Laboratories fell more than 6 per cent on Tuesday as the company's March quarter earnings failed to cheer investors. The stock dropped as much as 6.35 per cent to hit an intraday low of Rs 3,650.
-
Pharma Firm, India's Best-Performing Stock, Sees Wave of Optimistic Calls
In just about two weeks, at least four brokerages have raised their price targets on the shares of Divi's Laboratories -- one of the top producers of active pharmaceutical ingredients
-
Divis Lab Slumps 20% After US Regulator Issues Import Alert For Vizag Plant
Surjit Pal, pharma analyst at Prabhudas Lilladher, says Divis Lab shares could remain under pressure as its FY18 earnings would be hit due to the import alert.
-
Divi's Laboratories Slumps Over 30% In Just Two Days Over FDA Concerns
The Vizag plant is one of the biggest plants for Divi's. The company manufactures active pharmaceutical ingredients (APIs) and intermediates for generics among others at the Vizag manufacturing plant.
-
Divis Laboratories Announces Rs 80 Crore Bonanza For Employees
Divis Laboratories said that the special payment of Rs 79 crore will be reflected in its September quarter numbers.
-
Divis Laboratories Surges 8%, Hits New 52-Week High
Divis Laboratories shares surged over 8 per cent on Monday to hit a new 52-week high of Rs 2,129.
